The United Nations has set a goal for near universal HIV diagnosis and treatment for all by 2030. No country in Asia has hit ...

Around 78% of people who are living with HIV take a daily pill to manage their infection. These drugs work by preventing the ...

Simon Corcos, at Bradford Teaching Hospitals' HIV Clinic, has seen patients' outcomes transformed.

Thanks to antiretroviral therapy and improved control of viral hepatitis (HBV and HCV), people living with HIV generally live ...

The tissue microenvironments surrounding HIV-infected immune cells look a lot like those surrounding cancerous tumors, ...

New HIV infections and AIDS-related deaths are at their lowest levels in more than 30 years, a special report released by UNAIDS shows.

A review of non-vaccine HIV interventions highlights the strong preventive effects of long-acting PrEP, sustained ART, U=U, ...

Gilead raises its 2026 base-business outlook as HIV and PrEP momentum strengthens, while Trodelvy growth and two potential ...

Through the lens of National Geographic photographer Rena Effendi, meet the network of organizations and people turning HIV ...

Gilead Sciences’ HIV prevention business reached a milestone, exceeding $1 billion in quarterly sales for the first time. | ...

The biopharmaceutical company lowered its full-year forecast for Veklury after sales of the Covid-19 treatment fell 81% in ...

Prevention integration improved early HIV detection among women of reproductive age and supported stronger primary care ...